» Articles » PMID: 30987837

Dialysis Initiation, Modality Choice, Access, and Prescription: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2019 Apr 17
PMID 30987837
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

Globally, the number of patients undergoing maintenance dialysis is increasing, yet throughout the world there is significant variability in the practice of initiating dialysis. Factors such as availability of resources, reasons for starting dialysis, timing of dialysis initiation, patient education and preparedness, dialysis modality and access, as well as varied "country-specific" factors significantly affect patient experiences and outcomes. As the burden of end-stage kidney disease (ESKD) has increased globally, there has also been a growing recognition of the importance of patient involvement in determining the goals of care and decisions regarding treatment. In January 2018, KDIGO (Kidney Disease: Improving Global Outcomes) convened a Controversies Conference focused on dialysis initiation, including modality choice, access, and prescription. Here we present a summary of the conference discussions, including identified knowledge gaps, areas of controversy, and priorities for research. A major novel theme represented during the conference was the need to move away from a "one-size-fits-all" approach to dialysis and provide more individualized care that incorporates patient goals and preferences while still maintaining best practices for quality and safety. Identifying and including patient-centered goals that can be validated as quality indicators in the context of diverse health care systems to achieve equity of outcomes will require alignment of goals and incentives between patients, providers, regulators, and payers that will vary across health care jurisdictions.

Citing Articles

The impact of low-protein diet on residual renal function in dialysis patients: a systematic review and metaanalysis.

Xie J, Liu X, Ling Y, Ge S, Yao Y BMC Nephrol. 2025; 26(1):122.

PMID: 40050737 PMC: 11884191. DOI: 10.1186/s12882-025-04042-1.


Home dialysis as the incident modality in patients starting dialysis in West Virginia: role of the rural outreach kidney care clinic.

Schmidt R, Parravani A, Poling M, Diab A, Pellegrino B, Shawwa K J Nephrol. 2025; .

PMID: 40025398 DOI: 10.1007/s40620-025-02223-7.


In search of common ground - nephrologists' experiences in preparing and informing patients on the path to end-stage kidney disease.

Lindberg J, Johansson M, Brostrom L BMC Nephrol. 2025; 26(1):106.

PMID: 40021966 PMC: 11871651. DOI: 10.1186/s12882-025-04023-4.


Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study.

Imaizumi T, Komaba H, Hamano T, Nangaku M, Murotani K, Hasegawa T Clin Kidney J. 2025; 18(2):sfae398.

PMID: 39950153 PMC: 11822292. DOI: 10.1093/ckj/sfae398.


Co-Producing Peritoneal Dialysis Nursing Sensitive Indicators for Quality Care: A Multinational Consensus Building Design.

Baillie J, Bonner A, Guillouet S, Mikut C, Punzalan S, Kaczmarek A J Ren Care. 2025; 51(1):e70008.

PMID: 39873351 PMC: 11774010. DOI: 10.1111/jorc.70008.